XML 39 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Note 17 - Accounts Payable and Other Liabilities
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
17.
ACCOUNTS PAYABLE AND OTHER LIABILITIES

 
Accounts payable and other liabilities consisted of the following.

 
ACCOUNTS PAYABLE AND OTHER LIABILITIES
(Dollars in Thousands)
 
   
As of December 31,
 
   
2020
   
2019
 
Accounts payable
  $
162
    $
362
 
Redeemable financial instruments accrued interest
   
316
     
403
 
Accrued income tax    
99
     
-
 
Accrued interest payable
   
630
     
711
 
Accrued interest on securities sold, not yet purchased    
435
     
914
 
Payroll taxes payable
   
1,048
     
729
 
Counterparty cash collateral
   
41,119
     
9,524
 
Accrued expense and other liabilities
   
2,442
     
7,652
 
Accounts payable and other liabilities
  $
46,251
    $
20,295
 
 
The redeemable financial instrument accrued interest represents accrued interest on the JKD Capital Partners I LTD and the DGC Trust/CBF redeemable financial instruments.  See note
19.
 
When the Company enters into a reverse repo, the Company obtains collateral in excess of the principal of the reverse repo.  The Company accepts collateral in the form of liquid securities or cash.  To the extent the Company receives cash collateral, the Company includes it as a component of other liabilities (counterparty cash collateral) in the table above.  See note
11.
 
When the Company enters into repo transactions, the Company provides collateral to the Company's repo counterparty in excess of the principal balance of the repo.  If the value of the securities the Company provides as collateral increases, the Company
may
request a return of its collateral with a value equal to such increase.  In some cases, the repo counterparty will return cash instead of securities.  In that case, the Company includes the cash returned as a component of other liabilities (counterparty cash collateral) in the table above.  See note
11.